Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Transcript, audio, 8-K earnings release, 10-Q stay in one workspace.
Earnings call · FY2026 Q2
Executive readout · one minute
Read the call alongside every captured source. Transcript, audio, 8-K earnings release, 10-Q stay in one workspace.
Management tone
Positive
Net tone +15 · moderate hedging
Research coverage
4 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
How the reported period landed and where the business moved.
Listen and read together
The spoken word highlights as audio plays. Select any word to seek to that moment.
Hello, everyone. Thank you for joining us and welcome to the BlackRock TCP Capital Corp Q2 2026 earnings call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star 1 to raise your hand. To withdraw your question, press star 1 again. I will now hand the conference over to Alex Stahl, a member of the BlackRock TCP Capital Corp Investor Relations Team. Alex, please go ahead.
Thank you, operator. Before we begin, I will note that this conference call may contain forward-looking statements based on management's estimates and assumptions at the time such statements are made, which are not guarantees of future performance. Forward-looking statements involve risks and uncertainties, and actual results could differ materially from those projected. For more information, please refer to the risk factors discussed in our Form 10-Q and the Form 8-K filed with the SEC today, along with the associated press release. Any forward-looking statements made on this call are as of today and are subject to change without notice. Additionally, certain information discussed and presented may have been derived from third-party sources and has not been independently verified. Accordingly, we make no representation or warranty with respect to such information. Before we begin, I would also like to note that today's discussion includes references to certain non-GAAP financial measures, including adjusted net investment income. As detailed in our earnings press release, adjusted net investment income excludes the amortization of the purchase accounting discount resulting from our merger with BCIC and is calculated in accordance with GAAP. A full reconciliation of adjusted net investment income to GAAP net investment income, as well as other non-GAAP financial metrics is included in the earnings press release and 10Q. Earlier today, we issued a press release announcing our results for the second quarter and June 30, 2026, as well as the portfolio sale transaction we just completed. We posted a supplemental presentation with information on both to our website at www.tcpcapital.com. To view the slide presentation, which we will refer to on today's call, please click the Investor Relations link and select Events and Presentations. These documents should be reviewed in conjunction with the company's Form 10-Q, which was filed with the FEC earlier today. Now I will turn the call over to our Chairman, CEO, and Co-CIO, Phil Tsang.
Thank you, Alex, and thank you to our investors and analysts for joining us. Today, I'll start with an overview of the portfolio sale transaction we announced this morning, followed by the highlights of our second quarter 2026 performance. Then, Jason Merring, our president, will cover portfolio and investment activity, and Eric Cuellar, our CFO, will walk through our financial results and our balance sheet. I'll provide closing remarks before we open the call for questions. We're also joined by Dan Worrell, our co-CIO, who will be available for questions. Let me begin with the transaction. This is a milestone for TCPC that meaningfully accelerates the work already underway to strengthen our financial position and reshape our investment portfolio. This transaction materially lowers leverage, reduces investment position sizes, and significantly enhances our investment capacity while realizing a substantial premium to the value implied by TCPC's current share price. Looking forward, it provides substantially greater financial, investment, and operational flexibility, creating a stronger foundation for delivering long-term shareholder value. We will step through the transaction at a high level. Additional detail can be found in the subsequent events disclosure section of the 10-Q. TCPC transferred approximately $523 million of investments across 78 portfolio companies into a continuation vehicle sponsored by Pantheon. The assets sold comprise approximately 48% of the fair market value of our pre-transaction debt portfolio and have broadly similar sector, lien, and credit characteristics. The assets include all collateral underlying the recently issued BlackRock DLF 2026C CLO plus additional contributed investments. TCPC retained a direct interest in substantially all of the portfolio companies, transferring on average approximately two-thirds of each investment position to the vehicle. In addition, the company retained a 5% equity interest in the continuation vehicle, and TCPC's investment advisor will also act as the investment advisor for the vehicle without compensation. The continuation vehicle assumed all of the CLO liabilities. The transaction was priced at 95% of the December 31, 2025 gross fair market value of the assets sold, subject to customary adjustments, including unfunded commitments, portfolio repayments, and investment income generated prior to closing, and other items, as more fully outlined in Appendix A of the 8K we filed this morning. The transaction is expected to result in a NAV decline of approximately 10.4%, or $0.68 per share, based on June 30 NAV. Our Board of Directors obtained a third-party fairness opinion from Lincoln International in connection with the transaction. The strategic impact of the transaction is substantial. The approximately $152 million of proceeds were used primarily to reduce debt, and together with deconsolidation of the CLO and post-quarter end repayments, TCPC has reduced net leverage to approximately 0.4 times on a pro forma basis and unfunded commitments to below $40 million, significantly improving TCPC's financial flexibility and creating substantial new investment capacity. To help evaluate the best way to use that flexibility to create further long-term shareholder value the board has engaged keith briette and woods to assist with a strategic review this review will consider a range of options including but not limited to reinvesting the portfolio returning capital shareholders pursuing strategic combinations or other corporate transactions or some combination of these options i want to thank everyone involved in the transaction It was a complex process, and the hard work required reflects the firm's commitment to TCPC and its shareholders. With that, let me turn to our second quarter results. Apart from the transaction, we continued to make progress against our strategic priorities during the second quarter, including reducing non-accruals, strengthening the balance sheet, and advancing our portfolio repositioning efforts. While quarterly NAV performance reflected issuer-specific developments at a small number of portfolio companies, broader portfolio performance was generally in line with our expectations and we experienced strong repayment volumes. NAV in the quarter declined approximately 2.1% to $6.58 per share, primarily reflecting developments at Pluralsight, PVHC, and Zillion, as well as realized losses on our exits of AutoAlert and BCom. Nonaccruals declined to 1.6 percent of the portfolio at fair value and 7.4 percent at cost from 2.8 percent and 7.6 percent respectively at the end of the first quarter. The improvement was driven in large part by positive developments at Thrasio which repaid 22 million dollars. We removed our remaining 3.7 million dollar position at Thrasio from non-accrual status, as we expect this position will be paid down in full, given the current health of the business. As you may recall, we restructured our investment in Thrasio in early 2024, and we are pleased with this outcome, which we believe reflects the benefits of active portfolio management and patience. Repayment activity was strong in the second quarter, totaling $111.6 million in payoffs and paydowns, and resulting in net repayments of $86.6 million, which advanced our portfolio repositioning efforts. In addition to Thrasio, we received repayments of $14.9 million from StarRes, $13.1 million from AutoAlert, and an additional $48.7 million across five other companies. This repayment activity also strengthened the balance sheet. with net leverage declining to 1.38 times at quarter end from 1.48 times at the end of the first quarter. Following the portfolio sale transaction and post-quarter end repayments completed to date, net leverage is expected to decline to approximately 0.4 times on a pro-former basis and to less than 0.3 times after additional portfolio company paydowns from transactions that have been announced. Turning to capital allocation, on July 30, 2026, our Board declared a third quarter dividend of $0.17 per share, payable on September 30th to shareholders of record as of September 16th. We also repurchased 156,370 shares of TCPC stock during the second quarter at a weighted average price of $3.78 per share. Now, I'll turn the call over to Jason to discuss the portfolio and investment activity in more detail. Thanks, Phil, and welcome, everyone.
With the portfolio sale transaction now complete, I'll review our second quarter portfolio metrics and then highlight how the transaction and post quarter end repayments have positioned the portfolio going forward. At quarter end, the portfolio had fair market value of $1.29 billion invested across 134 portfolio companies in 35 industry sectors with an average position size of $9.6 million. 91.5% of the portfolio was invested in senior secured loans, all of which were floating rate, with the balance of the portfolio and equity. Substantially all new investments during the quarter were in first lien loans, bringing total first lien exposure to 89.8% on a fair value basis. Our largest investment based on fair value represented 8.9% of the portfolio, and the five largest investments accounted for 27.6%. As of June 30th, software represented 29.7% of the portfolio at fair value across 45 portfolio companies, with approximately 97% invested in debt and 3% in equity. This software exposure decreased modestly from 30.5% across 47 companies in Q1, primarily reflecting the successful exits of Persado and StarRes during the period. The current software portfolio was originated at a loan-to-value of approximately 26%, providing a considerable equity cushion. As we've discussed previously, we do not view software and potential AI risk as monolithic because certain segments are fundamentally more resilient than others. For some time, our underwriting has focused on systems of record with proprietary data assets and solutions that are deeply embedded in customer workflows or serve regulated end markets, which we believe are generally more insulated from AI-related disruption. In line with our focus on enhancing portfolio quality, discipline deployment, and strengthening our balance sheet, we intentionally kept investment activity limited and highly selective in the second quarter the majority of the 25 million dollars of capital deployed during the quarter was directed towards previously committed investments and we added one new borrower capitalizing on incumbency remains a priority for us and we continue to find compelling investment opportunities among our existing portfolio companies where we have long-standing relationships and industry experience as phil mentioned we saw meaningful payoffs and paydowns this quarter totaling 111.6 million dollars and resulting in net repayments of 86.6 million dollars subsequent to quarter end we also received 97.4 million dollars in additional repayments including 55.2 million dollars from motive technologies formerly known as keep truckin and $39 million from PICO Quantitative Trading. In addition, Domo announced that it had entered into a definitive agreement to sell substantially all of its operating businesses to Progress Software. We expect this will result in full repayment of our $69 million debt investment when the transaction closes in the fourth quarter. This is a significant positive development in our software book and another example of our ability to create value through active engagement with our portfolio companies. Together, these developments address more than $150 million of exposure across three larger portfolio positions and represent meaningful progress towards reducing concentration and advancing our broader portfolio repositioning efforts. We also see increasing repayment volumes as a sign of general borrower health. At the end of the second quarter, the weighted average effective yield on our portfolio was 10.5%. New investments had a weighted average yield of 9.4%, while those we exited had a weighted average yield of 10.9%. Current yields reflect lower base rates and spread compression consistent with the past several quarters. The portfolio sale transaction and post-quarter end repayments have significantly reduced our leverage and unfunded commitments and increased our new investment capacity, meaningfully accelerating our ability to reposition the portfolio. On a pro forma basis, the portfolio has a fair market value of $671 million invested across 132 portfolio companies with an average position size of approximately $5.1 million. If we include the additional investment capacity available at a modest one-time debt-to-equity ratio and assume no new software investments with that capacity, software would represent approximately 23% of the Proforma portfolio. That level would be further reduced to approximately 17% if you factor in the expected repayment of Domo. Following recent repayments and the portfolio sale transaction, we have approximately $395 million of liquidity, providing significant flexibility and investment capacity as the board evaluates how best to create long-term shareholder value we continue to benefit from the capabilities of the pfs platform which provides access to a broad opportunity set allowing us to remain highly selective and focused on granular high quality first lien investments now i'll turn the call over to era to discuss our financial results Thank you, Jason.
I'll begin with a review of our financial results for the second quarter of 2026. Total investment income was $40.0 million or $0.48 per share. This included recurring cash interest income of $0.35 per share, non-recurring income of $0.04 per share, recurring discount on fee amortization of $0.02 per share, PIC income of $0.04 per share, and dividend income of $0.03 per share. PIC income represented 7.6% of total investment income, down from 8.5% in Q1. Operating expenses for the second quarter were $21.9 million, or $0.26 per share, share, including $15.0 million, or $0.18 per share, of interest and other debt expenses. Net investment income was $18.1 million, or $0.22 per share, and adjusted net investment income was $17.5 million, or $0.21 per share. As of June 30, 2026, our cumulative total return did not exceed the total return hurdle. and therefore no incentive compensation was accrued for the quarter. Net realized losses for the quarter were $14.8 million, or $0.18 per share, driven primarily by a $10 million loss on the exit of our investment in AutoAlert. Net unrealized gains were $1.3 million, or $0.01 per share, Driven primarily by $11.3 million and reversals of previous unrealized losses related to AutoAlert and Thrasio, these gains were partially offset by markdowns in Pluralsight, PVHC, and Cilion, which together accounted for approximately $9.5 million of unrealized losses. Quarterly distributions to shareholders totaled $0.17 per share during the period. after net investment income realized in unrealized gains and losses and distributions nav declined by 14 cents per share to six dollars and 58 cents at june 30. the corresponding decrease in net assets for the quarter was 13.1 million dollars now i'll discuss our balance sheet and liquidity which benefited from both repayment and liability optimization activity during the quarter with improvements further accelerated by the portfolio sale transaction we completed today. During the quarter, we completed two important liability management initiatives. In May, we issued $406 million of CLO debt and used the proceeds to fully repay our TCPC funding to and merger sub-facilities, allowing us to term out a significant portion of our secure Additionally, given the level of paydowns and realizations, including those related to the portfolio transaction, and the absence of new development activity in our SBIC subsidiary, we elected to repay the remaining $107 million outstanding on our SBIC debt and subsequently surrender our license. We concluded there was limited benefit to maintaining the structure given the SBIC's cash position and fully drawn facility. Together, these two actions support our broader balance sheet objectives by extending liability maturities, increasing financing flexibility, and reducing complexity within our capital structure. As Jason mentioned, we also received $86.6 million in net repayments in the second quarter. As a result, total liquidity at the end of the second quarter was $533.7 million, including $376.2 million in available borrowing capacity under our revolvers and $157.5 million in cash. The combined weighted average interest rate on debt outstanding was 6.03% as of June 30, 2026. Net leverage was reduced to 1.38 times at quarter end, resulting in total debt-to-equity ratio of 1.66 times. With the combination of post quarter end repayment activity and this portfolio sale transaction, we estimate that our pro forma net leverage ratio further improved to approximately 0.4 times and would be less than 0.3 times if adjusted for future closure of the recently announced Domo transaction that Jason mentioned. Unfunded loan commitments represented 7.0% of our $1.29 billion investment portfolio, or $90 million including $53 million in revolver commitments as of June 30, 2026. Proforma for repayments and the portfolio sale transaction, unfunded loan commitments have been reduced to approximately $36 million. dollars. Overall, TCPC has a simpler balance sheet and has liquidity and substantially greater financial flexibility today than it did at the outset of the second quarter. Now, I'll turn the call back to Phil for closing remarks.
Thanks, Eric. Over the past year, we have made strong progress strengthening our financial position and reshaping our investment portfolio, and this This transaction pulls forward the realization of those efforts. The outcome is significantly lower leverage, reduced investment position sizes, and enhanced investment capacity. We believe these outcomes provide substantially greater financial, investment, and operational flexibility, creating a stronger foundation from which to evaluate and pursue strategic alternatives that can deliver greater long-term value to shareholders. We look forward to working with KBW and sharing more details as that process progresses as appropriate. With that, I'd like to thank our investors and analysts for their continued support of TCPC. Operator, we are now ready to open the call for questions.
We will now begin the question and answer session. Please limit yourself to one question and one follow-up. If you would like to ask a question, please press star 1 to raise your hand. To withdraw your question, press star 1 again. We ask that you pick up your handset when asking a question to allow for optimum sound quality. If you are muted locally, please remember to unmute your device. Please stand by while we compile the Q&A roster. Your first question comes from the line of Robert Dodd with Raymond James. Robert, your line is now open. Please go ahead.
Hi, guys, and congrats on kind of a landmark transaction. To your point, Phil, it kind of does raise the question, though, of what next? Can you address that like there's a strategic review? So kind of two components to the question on that, like how long do you think the strategic review, and obviously that's hard to say, but I think that's likely to take. And two, while that's ongoing, what are your likely strategies? Obviously, if part of the view is, should we reinvest or should we buy back stock, for example, among other things, are you likely to do either of those things while the review is ongoing, or is it kind of semi-set on your hands until the review is complete and you have a strategic mandate to pursue something.
Yeah, Robert, thanks for the question. So there's no specific timetable on the strategic review. Obviously, we are now in a very good position where we've created a great foundation from which to evaluate various alternatives that we otherwise weren't in a position to. So we feel that this transaction has given us and certainly accelerated our position to be here to evaluate a variety of alternatives, which includes the investment flexibility and capacity that we've talked about on the call, and also going deeper into a variety of other initiatives that we've been undertaking at the company and we've made good progress but this certainly accelerates it. In terms of specifically around timing, we'll see obviously KBW will do its work, work together with management and the board and come back with a variety of alternatives from which we can evaluate and maybe it's a combination of alternatives to drive longer-term shareholder value. In terms of how we're going to be investing over the subsequent period between now and then, we're going to continue doing what we've been doing, which is being prudent about our capital. And obviously, the strategic review goes hand-in-hand in how we allocate that capital. So, we're going to have that lens as we proceed through this period.
Got it. Thank you. Moving on from that for a second. And again, I think the transaction definitely puts you in a position where it's appropriate to review options before where your position was kind of dictating what you had to do before. So congrats on that. Moving on, I mean, to your point, like, I mean, I think you've got a Thrasio. So actually, you expect to be fully paid down. There's $69 million that should get repaid in the fourth quarter. There's a lot of repayments coming in as well. I mean, to that point, quite apart from the transaction, there's been a lot of movement as well. How much more can be done on that on the portfolio side kind of like this year? I mean, longer term, obviously, you know, things do what they do, but how many more things that could potentially be accelerated, maybe not purely from your actions, but in terms of beyond the transaction even, also reducing even beyond Delmar, et cetera, et cetera, some of the chunkier investments in the portfolio?
Yeah, well, maybe it's worthwhile, Robert, to take a step back about why we embarked on this transaction, because I think that speaks to what we can do in terms of continuing to drive shareholder value here in terms of repayments and, you know, portfolio positioning. But, you know, with our leverage level in the last several quarters, you know, we've been bumping up against 1.3, 1.4, even north of 1.4. It's really inhibited our ability to reposition the portfolio. I think you and other investors and analysts in the community have, you know, commented on that for good reason. You know, for example, we haven't been able to make meaningfully sized new investments, right, because of that leverage. So that's prevented us from diversifying the portfolio, it's prevented us from putting on newer investments to generate a more healthy income profile. And that limited capacity has also constrained our ability to buy back shares in a more meaningful way, aside from what we've done programmatically. um and also we've you know been inhibited from investing further uh or leaning further into strategic uh things or assets um that we would have otherwise wanted to go deeper on so so this this newfound financial and investment flexibility you know that's what we've accomplished here um and we could have done it organically and we actually made quite a bit of we've been making quite a bit of progress organically with, as you've seen, healthy repayments, non-accruals coming down, pay coming down, position sizes coming down. But that takes a long time. And I think you see that. And we have a pretty concentrated book, and that's how the portfolio was managed previously. So when we have a hit, it has a significant impact on NAV. So the path wasn't necessarily certain either right and um and what we achieved today with this announced sale is that we're here right we're at 0.4 times leverage you know 0.3 with the expected pay another pay down um and we have north of 300 million of new investment capacity so so we've we've really accelerated and that's why you know i started my comments saying this is a milestone for the company because i think it really is in in putting us in a good position so we're going to continue on the organic path in the interim you know obviously this new capacity gives us an ability to invest in new deals to accelerate the diversification of the portfolio to evaluate other shareholder friendly initiatives like buybacks or otherwise and that's what we're going to be looking out for in the near term.
Got it. I appreciate that. Thank you.
Thank you.
Your next question comes from the line of Paul Johnson with KBW Capital Markets. Paul, your line is now open.
Yeah, good afternoon. Thanks for taking my questions. Yeah, so I'm just curious, I wanted to know the impact from the transaction, the asset sale, 10.4%, does that also include, I guess, like transaction, any sort of transaction-related expenses for completing the sale?
Hi, Paul. It's Eric. The 10.4 does include the transaction-related expenses in there. I'd say the easiest way to think about the 10.4% approximate hit to NAV is by starting with that 5% discount that we stated as a portfolio discount. And then other customary adjustments that are done in these type of transactions, which give you sort of a rough effective discount of about 10%. And then your transaction expenses take that up to about 10.4% of a NAV hit.
Okay. Got it. That's clear. Thank you for that. And then I guess my other question would just be, I guess, you know, in terms of the strategic alternatives, obviously there's kind of a broad range of possibilities here. I mean, how should I guess we think about it in terms of, you know, is this kind of a resolution to all of the just kind of ongoing challenges from the years, you know, past or, you know, I think does BlackRock, I guess, have you know, any sort of attention here, maybe sort of like a rebuild in terms of kind of like the BlackRock BDC franchise. Thank you.
Hey, Paul, it's Phil. We don't have any comment on what we think, you know, will come out of the strategic evaluation process, and we're not going into it with a specific agenda, except for, you know, generating long-term shareholder value. So, So, you know, BlackRock, as you can see, is very committed to the success of the shareholders here. As you can see with this transaction, which was very complex and was, you know, a lot of effort around the table in getting this done. So, no preconceived notion of what's going to come out. But obviously, we wanted to hire a third-party advisor to really assist us and the board.
We have reached the end of the Q&A session. I will now turn the call back to Phil for closing remarks.
Thanks, Operator. Thank you all for joining our call today. And I'd also like to thank our team for their continued effort and hard work to TCPC. As always, please reach out with any questions. Thank you very much.
This concludes today's call. Thank you for attending. you may now disconnect.
SEC filing · Item 2.02
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
Filed Aug 6, 2026 · complete as-filed document